Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus
- PMID: 2467992
- PMCID: PMC250614
- DOI: 10.1128/JVI.63.5.1995-2001.1989
Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus
Abstract
Human cytomegalovirus contains an envelope glycoprotein of 58 kilodaltons (gp58). The protein, which is derived from a glycosylated precursor molecule of 160 kilodaltons via proteolytic cleavage, is capable of inducing neutralizing antibodies. We have mapped the epitopes recognized by the neutralizing monoclonal antibody 7-17 and a second antibody (27-287) which is not neutralizing. Overlapping fragments of the carboxy-terminal part of the open reading frame coding for gp58 were expressed in Escherichia coli as beta-galactosidase fusion proteins. The reactivities of antibodies 7-17 and 27-287 were determined by Western blot (immunoblot) analysis. Both antibodies recognized sequences between amino acids 608 and 625 of the primary gp58 translation product. The antibodies almost completely inhibited one another in a competitive binding assay with intact virus as antigen. Moreover, antibody 27-287 was able to inhibit the complement-independent neutralizing activity of antibody 7-17.
Similar articles
-
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.J Virol. 1993 Feb;67(2):703-10. doi: 10.1128/JVI.67.2.703-710.1993. J Virol. 1993. PMID: 7678304 Free PMC article.
-
The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope.J Gen Virol. 1990 Oct;71 ( Pt 10):2443-50. doi: 10.1099/0022-1317-71-10-2443. J Gen Virol. 1990. PMID: 1700066
-
A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.J Virol. 1992 Sep;66(9):5290-7. doi: 10.1128/JVI.66.9.5290-5297.1992. J Virol. 1992. PMID: 1323695 Free PMC article.
-
Mapping of viral epitopes with prokaryotic expression products.Arch Virol. 1990;110(1-2):1-24. doi: 10.1007/BF01310699. Arch Virol. 1990. PMID: 1689994 Free PMC article. Review.
-
Recent advances in the identification of significant human cytomegalovirus-encoded proteins.Transplant Proc. 1991 Jun;23(3 Suppl 3):64-9, discussion 69. Transplant Proc. 1991. PMID: 1648839 Review. No abstract available.
Cited by
-
Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response.J Virol. 2006 May;80(9):4591-600. doi: 10.1128/JVI.80.9.4591-4600.2006. J Virol. 2006. PMID: 16611919 Free PMC article.
-
Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H.J Virol. 1995 Oct;69(10):6047-53. doi: 10.1128/JVI.69.10.6047-6053.1995. J Virol. 1995. PMID: 7666509 Free PMC article.
-
Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.Clin Investig. 1993 Apr;71(4):270-6. doi: 10.1007/BF00184725. Clin Investig. 1993. PMID: 8386033 Review.
-
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.J Virol. 1993 Feb;67(2):703-10. doi: 10.1128/JVI.67.2.703-710.1993. J Virol. 1993. PMID: 7678304 Free PMC article.
-
A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs.J Gen Virol. 2021 Mar;102(3):001579. doi: 10.1099/jgv.0.001579. Epub 2021 Mar 17. J Gen Virol. 2021. PMID: 33729125 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases